Diethyl 2-propyl-1H-Imidazole-4,5-Dicarboxylatus CAS 144689-94-1 Puritas >99.0% (HPLC) Olmesartan Medoxomil Factory intermedium
Ruifu Chemical Supple Olmesartan Medoxomil media cum High Quality:
4,5-Dimethyl-1,3-Dioxol-2-Unum (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-Unum (DMDO-Cl) CAS 80841-78-7
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylatus CAS 144689-93-0
Diethyl 2-propyl-1H-Imidazole-4,5-Dicarboxylatus CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Nomen chemicum | Diethyl 2-propyl-1H-Imidazole-4,5-Dicarboxylate |
Synonyma | Diethyl 2-PropylImidazoledicarbonate;2-Propyl-1H-Imidazole-4,5-Dicarboxylic Acidum Diethyl Ester;2-Propylimidazoledicarboxylic Acidum Diethyl Ester |
CAS Number | 144689-94-1 |
CATTUS Number | RF-PI1872 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C12H18N2O4 |
M. Pondus | 254.29 |
Density | 1.160±0.06 g/cm3 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Pallidus ad Off-White pulveris |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Liquescens punctum | 83.0~88.0℃ |
Aqua Content (KF) | <0.50% |
Residere in Ignition | <0.20% |
Maximum Impuritas | <0.50% |
Totalis immunditias | <1.00% |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Olmesartan Medoxomil (CAS: 144689-63-4); |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylatus (CAS: 144689-94-1) medium est in synthesi Olmesartanae Medoxomil (CAS: 144689-63-4).Medoxomil Olmesartan curatione sanguinis pressi (hypertension).Princeps sanguinem pressura submittendo adiuvat ne ictus, cordis impetus, et difficultates renis.Olmesartan pertinet ad genus medicamentorum quod angiotensin receptor blockers (ARBs).Olmesartan operatur venas laxando ut sanguis facilius fluat.Sola adhiberi potest vel coniunctio cum aliis agentibus antihypertensivis.US Food and Drug Administration (FDA) decrevit beneficia Benicar pergere ad praeponderare periculum potentiale cum adhibitis ad curationem aegrorum magno sanguinis pressione secundum pittacium medicamentorum.